Bristol Myers Q2 revenue up 6% to $13.0B; raises full-year guidance

BRISTOL MYERS SQUIBB CO

Q2 revenues $12,973M (+6% YoY; +5% ex-FX); GAAP EPS $1.62 vs $0.64; non-GAAP EPS $2.04 vs $1.46.
Growth Portfolio revenues rose 15% (+14% ex-FX) to $7.6B, driven by key brands.
2026 revenue guidance raised to ~$49.0B-$50.0B; non-GAAP EPS guidance raised to $6.75-$7.00.
CEO cites consistent execution and pipeline progress as basis for raised outlook.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.